✦ LIBER ✦

Comparative Study of Both Versions of an Immunoassay Commercialized for Therapeutic Drug Monitoring of Adalimumab in Rheumatoid Arthritis

✍ Scribed by Llinares-Tello, Francisca; Rosas, José; de la Torre, Inmaculada; Valor, Lara; Barber, Xavier; Senabre, José Miguel

Book ID: 122285424
Publisher: Elsevier Science
Year: 2014
Tongue: Spanish
Weight: 430 KB
Volume: 10
Category: Article
ISSN: 2173-5743
DOI: 10.1016/j.reumae.2013.12.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative effectiveness and survival o

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

✍ Flouri, Irini; Markatseli, Theodora E.; Voulgari, Paraskevi V.; Boki, Kyriaki A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 696 KB

PAR13 A PROSPECTIVE STUDY COMPARING DRUG

PAR13 A PROSPECTIVE STUDY COMPARING DRUG UTILIZATION PATTERNS AND COST OF TREATMENT OF PATIENTS FOR RHEUMATOID ARTHRITIS IN KERALA, INDIA

✍ TP Meleth; J Varkey; J Philip; L Lai 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

The comparative effects of phenylbutazon

The comparative effects of phenylbutazone and G27202 (metabolite i) in patients with rheumatoid arthritis: An assessment of methods for antirheumatic drug evaluation

✍ Phyllis P. Vaughn; David S. Howell; Iris M. Kiem 📂 Article 📅 1959 🏛 John Wiley and Sons 🌐 English ⚖ 747 KB

An open-label pilot study of the effecti

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

✍ Arie E. van der Bijl; Ferdinand C. Breedveld; Christian E. Antoni; Joachim R. Ka 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 182 KB

P28 A study to compare simplified diseas

P28 A study to compare simplified disease activity index and DAS28 as an index for disease activity in patients of rheumatoid arthritis

✍ R Sharma; M Thakre; NV Jayachandran; S Kanchinadham; S Agrawal; L Rajasekhara; G 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase IIb dose-ranging study of the oral

Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs

✍ Roy Fleischmann; Maurizio Cutolo; Mark C. Genovese; Eun Bong Lee; Keith S. Kanik 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 4 views